STOCK TITAN

electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference 

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

electroCore, a commercial-stage bioelectronic medicine company (NASDAQ: ECOR), will present at the HC Wainwright 23rd Annual Global Investment Conference, taking place virtually from September 13-15, 2021. The presentation will be available online starting at 7:00 am EDT on September 13. Investors can register for the conference through provided links. A webcast replay will be accessible on the company’s website after the conference. electroCore focuses on non-invasive vagus nerve stimulation therapy aimed at treating conditions like migraines and cluster headaches.

Positive
  • None.
Negative
  • None.

ROCKAWAY, NJ, Aug. 31, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation at the HC Wainwright 23rd Annual Global Investment Conference. The conference is taking place virtually from September 13 - 15, 2021. Details for the presentation are as follows:

HC Wainwright 23rd Annual Global Investment Conference:
Date: Monday, September 13, 2021
Time: the presentation will be available online beginning at 7:00 am EDT
Investors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.


FAQ

When will electroCore present at the HC Wainwright 23rd Annual Global Investment Conference?

electroCore will present on September 13, 2021, starting at 7:00 am EDT.

How can investors register for the HC Wainwright conference for electroCore?

Investors can register for the conference through the links provided in the press release.

Where can I find the webcast replay of electroCore's presentation after the conference?

The webcast replay will be available on the Investor section of electroCore's website after the conference.

What is the focus of electroCore's bioelectronic medicine?

electroCore specializes in non-invasive vagus nerve stimulation therapy primarily for treating migraines and cluster headaches.

What stock symbol represents electroCore?

electroCore is listed under the stock symbol ECOR.

electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

71.05M
4.91M
25.02%
16.11%
0.67%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ROCKAWAY